News
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article ...
4 February 2025 LSIPR sister title WIPR releases USA Patents Rankings, divided into categories of non-contentious and ...
Disputed drug forms part of a multi-billion dollar franchise for J&J, ranking among its largest revenue drivers in mental health treatment | Appeals court rejects arguments that patent claims would ...
For startups, getting a drug to market is a marathon but founders need to think beyond filing patents to win over investors, ...
LSPN panellists from Mathys & Squire discuss recent developments affecting the EPO Boards of Appeal and decisions emerging ...
German and Finnish pharma giants sue Indian rival in Delaware court | Dispute centres on generic bid for prostate cancer ...
Major team hire by premier European litigation firm | September opening adds to successful UPC practice | Hire is a ‘landmark’ moment says Penny Gilbert. Already registered? If you don't have a login ...
Judge says sale of genetic data is ‘scary proposition’ but that blanket ban could result in missed opportunities | Former CEO ...
Biocon failed to provide critical information about proposed denosumab product, Amgen claims | Company expects ‘sales erosion ...
8 November 2017 Generic drugs maker Accord Healthcare has lost a battle to have a patent invalidated at the English High ...
17 June 2025 Ex-co-head of life sciences at previous firm brings expertise in multi-jurisdictional patent disputes involving ...
26 June 2025 Insurance company Cigna claims Bristol Myers Squibb may have caused overpayments of ‘billions’ of dollars after ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results